Hyperchloremic metabolic acidosis in the kidney transplant patient

References

• Georges B, Huart J, Krzesinski JM, et al. [Screening and management of metabolic acidosis in patients with chronic kidney disease]. Rev Med Suisse. 2018;14(615):1455–1458.
   PubMedGoogle Scholar
• Skiba K, Gojowy D, Szotowska M, et al. Metabolic acidosis in kidney transplant recipients. Pol Arch Intern Med. 2018 Oct 31;128(10):587–593.
   PubMedGoogle Scholar
• Messa PG, Alfieri C, Vettoretti S. Metabolic acidosis in renal transplantation: neglected but of potential clinical relevance. Nephrol Dial Transplant. 2016;31(5):730–736.
   PubMed Web of Science ®Google Scholar
• Moorthi K, Batlle D. Renal tubular acidosis. In: Gennari J, Adrogue H, Galla J, et al., editors. Acid base disoreders and their treatments. Boca Raton: Taylor & Francis; 2010. p. 273–304.
   Google Scholar
• Schwarz C, Benesch T, Kodras K, et al. Complete renal tubular acidosis late after kidney transplantation. Nephrol Dialysis Transplantation. 2006;21:2615–2620.
   PubMed Web of Science ®Google Scholar
• Golembiewska E, Ciechanowski K. Renal tubular acidosis--underrated problem? Acta Biochim Pol. 2012;59(2):213–217.
   PubMed Web of Science ®Google Scholar
• Palazzo V, Provenzano A, Becherucci F, et al. The genetic and clinical spectrum of a large cohort of patients with distal renal tubular acidosis. Kidney Int. 2017;91(5):1243–1255.
   PubMed Web of Science ®Google Scholar
• Dagan A, Eisenstein B, Bar-Nathan N, et al. Tubular and glomerular function in children after renal transplantation. Pediatr Transplant. 2005;9:440–444.
   PubMed Web of Science ®Google Scholar
• Riveiro-Barciela M, Campos-Varela I, Tovar JL, et al. Hyperkalemic distal renal tubular acidosis caused by immunosuppressant treatment with tacrolimus in a liver transplant. Transplant Proc. 2011;43:4016–4018.
   PubMed Web of Science ®Google Scholar
• Last accessed on 25th February 2019. https://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=ES&Expert=47159
   Google Scholar
• Last accessed on 25th February 2019. https://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=ES&Expert=18
   Google Scholar
• Tanrisev M, Gungor O, Kocyigit I, et al. Renal tubular acidosis in renal transplant patients: the effect of immunosuppressive drugs. Ann Transplant. 2015;20:85–91.
   PubMed Web of Science ®Google Scholar
• Malik SI, Naqvi R, Ahmed E, et al. Prevalence and risk factors of renal tubular acidosis after kidney transplantation. J Pak Med Assoc. 2011;61(1):23–27.
   PubMed Web of Science ®Google Scholar
• Keven K, Ozturk R, Sengul S, et al. Renal tubular acidosis after kidney transplantation—incidence, risk factors and clinical implications. Nephrol Dialysis Transplantation. 2007;22:906–910.
   PubMed Web of Science ®Google Scholar
• Rangel EB, Gomes SA, Machado PG, et al. Severe hyperkalemic type 4 renal tubular acidosis after kidney transplantation: a case report. Transplant Proc. 2006;38(9):3112–3115.
   PubMed Web of Science ®Google Scholar
• Musso CG. Potassium metabolism in patients with chronic kidney disease. Part II: patients on dialysis (stage 5). Int Urol Nephrol. 2004;36(3):469–472.
   PubMedGoogle Scholar
• Adamczak M, Masajtis-Zagajewska A, Mazanowska O, et al. Diagnosis and treatment of metabolic acidosis in patients with chronic kidney disease - position statement of the working group of the polish society of nephrology. Kidney Blood Press Res. 2018;43(3):959–969.
   PubMed Web of Science ®Google Scholar
• Ambühl PM. Posttransplant metabolic acidosis: a neglected factor in renal transplantation? Curr Opin Nephrol Hypertens. 2007;16:379–387.
   PubMed Web of Science ®Google Scholar
• Yakupoglu HY, Corsenca A, Wahl P, et al. Posttransplant acidosis and associated disorders of mineral metabolism in patients with a renal graft. Transplantation. 2007;84(9):1151–1157.
   PubMed Web of Science ®Google Scholar
• Kocyigit I, Unal A, Kavuncuoglu F, et al. Renal tubular acidosis in renal transplantation recipients. Ren Fail. 2010;32:687–690.
   PubMed Web of Science ®Google Scholar
• Katalinić L, Blaslov K, Đanić-Hadžibegović A, et al. Metabolic acidosis- An underestimated problem after kidney transplantation? Acta Clin Croat. 2015;54:486–491.
   PubMed Web of Science ®Google Scholar
• Hjelmesaeth J, Hagen M, Hartmann A, et al. The impact of impaired insulin release and insulin resistance on glucose intolerance after renal transplantation. Clin Transplant. 2002 Dec;16(6):389–396.
   PubMed Web of Science ®Google Scholar
• Cosio FG, Pesavento TE, Osei K, et al. Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years. Kidney Int. 2001;59(2):732–737.
   PubMed Web of Science ®Google Scholar
• Roth D, Milgrom M, Esquenazi V, et al. Posttransplant hyperglycemia. Increased incidence in cyclosporine-treated renal allograft recipients. Transplantation. 1989;47(2):278–281.
   PubMed Web of Science ®Google Scholar
• Vincenti F, Friman S, Scheuermann E, et al. DIRECT (diabetes incidence after renal transplantation: neoral C monitoring versus tacrolimus) investigators. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant. 2007 Jun ;7(6):1506–1514. Epub 2007 Mar 12. Erratum in: Am J Transplant. 2008 Jan;8(1):1.Am J Transplant. 2008 Apr;8(4):908.
   PubMed Web of Science ®Google Scholar
• Heldal TF, Ueland T, Jenssen T, et al. Inflammatory and related biomarkers are associated with post-transplant diabetes mellitus in kidney recipients: a retrospective study. Transpl Int. 2018;31(5):510–519.
   PubMed Web of Science ®Google Scholar
• Gyory AZ, Stewart JH, George CR, et al. Renal tubular acidosis, acidosis due to hyperkalemia, hypercalcemia, disordered citrate metabolism and other tubular dysfunctions following human renal transplantation. Q j med. 1969;38(150):231–254.
   PubMedGoogle Scholar
• Harris AN, Grimm PR, Lee HW, et al. Mechanism of hyperkalemia-induced metabolic acidosis. J Am Soc Nephrol. 2018;29(5):1411–1425.
   PubMed Web of Science ®Google Scholar
• Adrogue HJ, Wesson DE. Acid-base. Houston: Gemini; 1991.
   Google Scholar
• Blankenstein KI, Borschewski A, Labes R, et al. Calcineurin inhibitor cyclosporine A activates renal Na-K-Cl cotransporters via local and systemic mechanisms. Am J Physiol Renal Physiol. 2017 Mar 1;312(3):F489–F501.
   PubMed Web of Science ®Google Scholar
• Lin W, Mou L, Tu H, et al. Clinical analysis of hyperkalemic renal tubular acidosis caused by calcineurin inhibitors in solid organ transplant recipients. J Clin Pharm Ther. 2017;42(1):122–124.
   PubMed Web of Science ®Google Scholar
• Better OS, Chaimowitz C, Alroy GG, et al. Spontaneous remission of the defect in urinary acidification after cadaver kidney homotransplantation. Lancet. 1970;1(7638):110–112.
   PubMed Web of Science ®Google Scholar
• François H, Mariette X. Renal involvement in primary Sjögren syndrome. Nat Rev Nephrol. 2016;12(2):82–93.
   PubMed Web of Science ®Google Scholar
• Banhara PB, Gonçalves RT, Rocha PT, et al. Tubular dysfunction in renal transplant patients using sirolimus or tacrolimus. Clin Nephrol. 2015;63(6):331–337.
   Web of Science ®Google Scholar
• Wiegand A, Ritter A, Graf N, et al. Preservation of kidney function in kidney transplant recipients by alkali therapy (preserve-transplant study): rationale and study protocol. BMC Nephrol. 2018 Jul 13;19(1):177.
   PubMed Web of Science ®Google Scholar
• Kulkarni M. Type 4 renal tubular acidosis in a kidney transplant recipient. Biomed J. 2016;39(1):85–86.
   PubMed Web of Science ®Google Scholar
• Starke A, Corsenca A, Kohler T, et al. Correction of metabolic acidosis with potassium citrate in renal transplant patients and its effect on bone quality. Clin J Am Soc Nephrol. 2012;7(9):1461–1472.
   PubMed Web of Science ®Google Scholar
• Ali SR, Shaheen I, Young D, et al. Fludrocortisone-a treatment for tubulopathy post-paediatric renal transplantation: A national paediatric nephrology unit experience. Pediatr Transplant. 2018 Mar;22:2.
   Web of Science ®Google Scholar
• Schulte K, Vollmer C, Klasen V, et al. Late conversion from tacrolimus to a belatacept-based immuno-suppression regime in kidney transplant recipients improves renal function, acid-base derangement and mineral-bone metabolism. J Nephrol. 2017 Aug;30(4):607–615.
   PubMed Web of Science ®Google Scholar